Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients
dc.contributor.author | Dubberke, E.R. | |
dc.contributor.author | Reske, K.A. | |
dc.contributor.author | Olsen, M.A. | |
dc.contributor.author | Bommarito, K. | |
dc.contributor.author | Cleveland, A.A. | |
dc.contributor.author | Silveira, F.P. | |
dc.contributor.author | Schuster, M.G. | |
dc.contributor.author | Kauffman, C.A. | |
dc.contributor.author | Avery, R.K. | |
dc.contributor.author | Pappas, P.G. | |
dc.contributor.author | Chiller, T.M. | |
dc.date.accessioned | 2018-05-15T20:16:09Z | |
dc.date.available | 2019-06-03T15:24:19Z | en |
dc.date.issued | 2018-04 | |
dc.identifier.citation | Dubberke, E.R.; Reske, K.A.; Olsen, M.A.; Bommarito, K.; Cleveland, A.A.; Silveira, F.P.; Schuster, M.G.; Kauffman, C.A.; Avery, R.K.; Pappas, P.G.; Chiller, T.M. (2018). "Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients." Transplant Infectious Disease 20(2): n/a-n/a. | |
dc.identifier.issn | 1398-2273 | |
dc.identifier.issn | 1399-3062 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/143790 | |
dc.description.abstract | BackgroundClostridium difficile infection (CDI) is a common complication of lung and allogeneic hematopoietic cell (HCT) transplant, but the epidemiology and outcomes of CDI after transplant are poorly described.MethodsWe performed a prospective, multicenter study of CDI within 365 days post‐allogeneic HCT or lung transplantation. Data were collected via patient interviews and medical chart review. Participants were followed weekly in the 12 weeks post‐transplant and while hospitalized and contacted monthly up to 18 months post‐transplantation.ResultsSix sites participated in the study with 614 total participants; 4 enrolled allogeneic HCT (385 participants) and 5 enrolled lung transplant recipients (229 participants). One hundred and fifty CDI cases occurred within 1 year of transplantation; the incidence among lung transplant recipients was 13.1% and among allogeneic HCTs was 31.2%. Median time to CDI was significantly shorter among allogeneic HCT than lung transplant recipients (27 days vs 90 days; P = .037). CDI was associated with significantly higher mortality from 31 to 180 days post‐index date among the allogeneic HCT recipients (Hazard ratio [HR] = 1.80; P = .007). There was a trend towards increased mortality among lung transplant recipients from 120 to 180 days post‐index date (HR = 4.7, P = .09).ConclusionsThe epidemiology and outcomes of CDI vary by transplant population; surveillance for CDI should continue beyond the immediate post‐transplant period. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | Clostridium difficile | |
dc.subject.other | epidemiology | |
dc.subject.other | hematopoetic cell transplant | |
dc.subject.other | lung transplant | |
dc.subject.other | outcomes | |
dc.title | Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Microbiology and Immunology | |
dc.subject.hlbsecondlevel | Medicine (General) | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/143790/1/tid12855_am.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/143790/2/tid12855.pdf | |
dc.identifier.doi | 10.1111/tid.12855 | |
dc.identifier.source | Transplant Infectious Disease | |
dc.identifier.citedreference | Paudel S, Zacharioudakis IM, Zervou FN, Ziakas PD, Mylonakis E. Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta‐analysis of published studies. PLoS One. 2015; 10: e0124483. | |
dc.identifier.citedreference | Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998; 40: 1 ‐ 15. | |
dc.identifier.citedreference | Kyne L, Sougioultzis S, McFarland LV, Kelly CF. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol. 2002; 23: 653 ‐ 659. | |
dc.identifier.citedreference | Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011; 365: 1693 ‐ 1703. | |
dc.identifier.citedreference | McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile ‐associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990; 162: 678 ‐ 684. | |
dc.identifier.citedreference | Honda H, Dubberke ER. Clostridium difficile infection in solid organ transplant recipients. Curr Opin Infect Dis. 2014; 27: 336 ‐ 341. | |
dc.identifier.citedreference | Alonso CD, Treadway SB, Hanna DB, et al. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2012; 54: 1053 ‐ 1063. | |
dc.identifier.citedreference | Boyle NM, Magaret A, Stednick Z, et al. Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrob Resist Infect Control. 2015; 4: 41. | |
dc.identifier.citedreference | Chakrabarti S, Lees A, Jones SG, Milligan DW. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft‐versus‐host disease and non‐relapse mortality. Bone Marrow Transplant. 2000; 26: 871 ‐ 876. | |
dc.identifier.citedreference | Chopra T, Chandrasekar P, Salimnia H, Heilbrun LK, Smith D, Alangaden GJ. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation. Clin Transplant. 2011; 25: E82 ‐ E87. | |
dc.identifier.citedreference | Kamboj M, Xiao K, Kaltsas A, et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027. Biol Blood Marrow Transplant. 2014; 20: 1626 ‐ 1633. | |
dc.identifier.citedreference | Kinnebrew MA, Lee YJ, Jenq RR, et al. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. PLoS One. 2014; 9: e90158. | |
dc.identifier.citedreference | Leung S, Metzger BS, Currie BP. Incidence of Clostridium difficile infection in patients with acute leukemia and lymphoma after allogeneic hematopoietic stem cell transplantation. Infect Control Hosp Epidemiol. 2010; 31: 313 ‐ 315. | |
dc.identifier.citedreference | Mani S, Rybicki L, Jagadeesh D, Mossad SB. Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients. Bone Marrow Transplant. 2016; 51: 713 ‐ 717. | |
dc.identifier.citedreference | Willems L, Porcher R, Lafaurie M, et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transplant. 2012; 18: 1295 ‐ 1301. | |
dc.identifier.citedreference | Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002; 235: 363 ‐ 372. | |
dc.identifier.citedreference | Lee JT, Kelly RF, Hertz MI, Dunitz JM, Shumway SJ. Clostridium difficile infection increases mortality risk in lung transplant recipients. J Heart Lung Transplant. 2013; 32: 1020 ‐ 1026. | |
dc.identifier.citedreference | Pant C, Anderson MP, O’Connor JA, Marshall CM, Deshpande A, Sferra TJ. Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database. Transpl Infect Dis. 2012; 14: 540 ‐ 547. | |
dc.identifier.citedreference | Dubberke ER, Reske KA, Srivastava A, et al. Clostridium difficile ‐associated disease in allogeneic hematopoietic stem‐cell transplant recipients: risk associations, protective associations, and outcomes. Clin Transplant. 2010; 24: 192 ‐ 198. | |
dc.identifier.citedreference | Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16: 128 ‐ 140. | |
dc.identifier.citedreference | Riddle DJ, Dubberke ER. Clostridium difficile infection in solid organ transplant recipients. Curr Opin Organ Transplant. 2008; 13: 592 ‐ 600. | |
dc.identifier.citedreference | Lee JT, Hertz MI, Dunitz JM, et al. The rise of Clostridium difficile infection in lung transplant recipients in the modern era. Clin Transplant. 2013; 27: 303 ‐ 310. | |
dc.identifier.citedreference | Gunderson CC, Gupta MR, Lopez F, et al. Clostridium difficile colitis in lung transplantation. Transpl Infect Dis. 2008; 10: 245 ‐ 251. | |
dc.identifier.citedreference | Docampo MD, Auletta JJ, Jenq RR. Emerging influence of the intestinal microbiota during allogeneic hematopoietic cell transplantation: control the gut and the body will follow. Biol Blood Marrow Transplant. 2015; 21: 1360 ‐ 1366. | |
dc.identifier.citedreference | Dubberke ER, Olsen MA, Stwalley D, et al. Identification of Medicare recipients at highest risk for Clostridium difficile infection in the US by population attributable risk analysis. PLoS One. 2016; 11: e0146822. | |
dc.identifier.citedreference | Prescott HC, Dickson RP, Rogers MA, Langa KM, Iwashyna TJ. Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med. 2015; 192: 581 ‐ 588. | |
dc.identifier.citedreference | Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clinical Microbiol Rev. 2013; 26: 604 ‐ 630. | |
dc.identifier.citedreference | Dubberke ER, Reske KA, Olsen MA, et al. Risk for Clostridium difficile infection after allogeneic hematopoietic cell transplant remains elevated in the postengraftment period. Transplant Direct. 2017; 3: e145. | |
dc.identifier.citedreference | Jenq RR, Ubeda C, Taur Y, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med. 2012; 209: 903 ‐ 911. | |
dc.identifier.citedreference | Taur Y, Jenq RR, Perales MA, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014; 124: 1174 ‐ 1182. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.